Navigation Links
InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma
Date:3/3/2010

For diagnostic and monoclonal antibody production, Zap-Hybridoma improves target antibody purity and hybridoma productivity.

Fort Collins, CO (PRWEB) March 3, 2010 -- InVitria’s launch of Zap-Hybridoma provides a powerful solution for hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product.

Zap-Hybridoma was developed by InVitria’s Cell Culture Development team as an answer to many of the challenges facing scientists working with hybridoma cell culture. “Not only can Zap-Hybridoma increase productivity, it delivers consistent results and allows hybridoma cells to more quickly adapt away from FBS (fetal bovine serum),” said Dr. Steve Pettit, InVitria’s Director of Cell Culture Development. “We tested Zap-Hybridoma in six of the leading commercial hybridoma media on the market today and observed faster cell growth, a 50% average increase in maximum cell density and increased monoclonal antibody yield when compared to the recommended use of the manufacturer.”

“Zap-Hybridoma is an innovation InVitria is proud to bring to its customers so they can achieve better performance more consistently,” said Scott Deeter, InVitria President and CEO. "We developed Zap-Hybridoma to give users an IgG free alternative to FBS without sacrificing performance.”
                                                                                                                                                                                
Zap-Hybridoma / FBS
IgG Free                                                                                YES / NO
Consistent Performance                                                    YES / NO
Defined & Animal Component-Free                                YES / NO
Accelerates Adaptation to Serum-Free Media                YES / NO
Lowers Operating & Capital Costs                                   YES / NO
   
To order your sample of Zap-Hybridoma or to receive more information, please visit Zap-Hybridoma.

About InVitria – InVitria.com
InVitria specializes in cell culture media optimization for the biotechnology industry. InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria’s product solutions, e-mail info(at)InVitria(dot)com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/ZapHybridoma/InVitria/prweb3678694.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. InVitria Sponsors 2010 Biomanufacturing Summit
2. Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance
3. InVitrias Better Ingredients for Better Media to be Showcased at BPI 09
4. InVitria Reveals Technology to Optimize Hybridoma Production Performance
5. InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
6. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
7. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
8. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
9. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
10. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
11. InVitria Expands Sales Team
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma  
(Date:1/20/2017)... ... January 20, 2017 , ... ... the next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System ... competition, SpineFrontier is focused on technique driven product solutions that provide maximum ...
(Date:1/19/2017)... India , Jan. 19, 2017  Market Research Future has ... Global Market for Liquid Biopsy is growing rapidly and expected to ... Market Highlights ... The Global Liquid Biopsy Market has been assessed as a ... growth figures and boom in the coming future. There has been ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi ... device open-access capability and technology platform, today announced ... leading biology focused preclinical drug discovery contract research ... will become a wholly-owned subsidiary of WuXi, and ... competences and providing greater services. The acquisition will ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... development (R&D), today announced the launch of Data Science Services , ... rapidly evolving field of precision medicine. , Data Science Services allows ...
Breaking Biology Technology:
(Date:1/11/2017)... 2017  Michael Johnson, co-founder of Visikol Inc. a company originally ... been named to the elite "Forbes 30 Under 30" list in ... people in 20 fields nationwide to be recognized as a leader ... were selected. ... is currently a PhD candidate at Rutgers University. ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/4/2017)... the thousands of attendees at this year,s International Consumer Electronics Show (CES), ... measurement devices and services, will be featuring its new line of ULTRA ... special CES Exhibit Suite , the new upper arm and wrist ... WellnessConnected product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):